Jump to content

Draft:Hooman Oktaei

From Wikipedia, the free encyclopedia
  • Comment: Wikipedia is not for advertising one's academic career. Drmies (talk) 21:12, 19 May 2025 (UTC)


Dr. Hooman Oktaei is an endocrinologist and diabetes specialist. He has contributed to significant research in diabetes prevention, particularly through his work on the Diabetes Prevention Program (DPP) and its long-term follow-up, the Diabetes Prevention Program Outcomes Study (DPPOS).The Economic Report has reported total annual cost of diabetes in 2022 is $412.9 billion and prevention of diabetes mellitus as one of main works of Dr. Oktaei can have a huge impact. One of his notable studies, titled "Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study," was published in 2021. This research aimed to determine whether metformin or lifestyle modification could lower rates of all-cause and cause-specific mortality among adults at high risk for type 2 diabetes. The study found that, over a median of 21 years, metformin did not significantly reduce mortality rates compared to placebo. However, lifestyle interventions were associated with a lower risk of death from cardiovascular disease and cancer, highlighting the long-term benefits of lifestyle changes in diabetes prevention. Dr. Oktaei's expertise in endocrinology and diabetes is further demonstrated by his board certifications in Internal Medicine and Endocrinology, Diabetes & Metabolism, as well as his academic background from the University of Tennessee. His research contributes to the growing body of evidence supporting the effectiveness of lifestyle interventions in preventing type 2 diabetes and improving long-term health outcomes.


References

[edit]

[1] [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49]

  1. ^ The Diabetes Prevention Program Research Group including H. Oktaei. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin The New England Journal of Medicine (NEJM) 2002;346:393-403 Available from URL: https://www.nejm.org/doi/full/10.1056/NEJMoa012512
  2. ^ Hooman Oktaei, M. H. Shokouh-Amiri, O. Gaber, L. Gaber A. Salem, A. E. Kitabchi, The Effect of Chronic Hyperinsulinemia on Fibrous Tissue of Ventricular Myocardium in Nontransplant Model of Chronic Hyperinsulinemic Dogs. Journal of Investigative Medicine, 2001 Available from: URL: https://journals.sagepub.com/doi/abs/10.1177/108155890105201S610
  3. ^ Childress RD, Qureshi MN, Kasparova M, Oktaei H, Williams-Cleaves B, Solomon SS Thyrotoxicosis presenting as hypogonadism: a case of central hyperthyroidism. The American Journal of the Medical Sciences. 2004 Nov;328(5):295-8. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/15545848/
  4. ^ Hooman Oktaei, L. VanMiddlesworth, A.E. Kitabchi, 2005. Thyrotoxic Hypokalemic Periodic Paralysis in An African American Male. Journal of Investigative Medicine, 2005 Available from: URL: https://journals.sagepub.com/doi/10.1177/1081558905053001606
  5. ^ H. Oktaei, M.H. Shokouh-Amiri, L. Gaber, O. Gaber, A. Salem, A.E. Kitabchi. The Effect of Chronic Hyperinsulinemia on Coronary Arteries in Nontransplant Dog Model. Journal of Investigative Medicine. Volume 53, Issue 1_part_5. First published January 2005 Available from: URL: https://us.sagepub.com/en-us/nam/journal-of-investigative-medicine/journal203786
  6. ^ Amanda L. Long, Hooman Oktaei , Richard Dale Childress, S. Solomon. Rapid Reversal of Lithium-Induced Hyperparathyroidism: A Case Report. 93rd Annual Meeting of the Endocrine Society: abstr. P1-239, 4 Jun 2011. Available from: URL: http://www.endo-society.org – USA
  7. ^ Rabia Rehman. Hooman Oktaei, Dale Childress, Solomon S. Solmon. Monogenic Diabetes Chapter, First Online: 01 Robert J. Ferry, Jr. Management of Pediatric Obesity and Diabetes. January 2011, pp 349–365
  8. ^ Rabia Abdul Rehman, Richard Dale Childress, Solomon S. Solomon, Hooman Oktaei.; Neuroendocrine tumor presenting as metastatic carcinoid and later as insulinoma: a rare metamorphosis; Pagepress endocrinology studies. VOL. 2 NO. 2 (2012) Available from: URL: HTTPS://WWW.OALIB.COM/RESEARCH/2818530
  9. ^ Fariha Salman. Solomon Solomon, Hooman Oktaei, Omid Rad Pour. Recurrence of Thyrotoxicosis (GRAVES' ) After a Protracted Period of Hypothyroidism Following RAI Therapy. Endocrine Practice Vol. 22Supplementp252Published in issue: May, 2016 Available from: URL: https://www.sciencedirect.com/science/article/abs/pii/S1530891X20447494?via%3Dihub
  10. ^ Salman F, Oktaei H, Solomon S, Nyenwe E ; Recurrent Graves' hyperthyroidism after prolonged radioiodine-induced hypothyroidism. Ther Adv Endocrinol Metab. 2017 Jul;8(7):111-115. Available from: URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5602214/
  11. ^ Anita Eapen and Hooman Oktaei. Biotin Masquerading as Subclinical Hyperthyroidism. Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020 Available from: URL: https://doi.org/10.1210/jendso/bvaa046.1289
  12. ^ Zhao Liu, MD, Hooman Oktaei, MD; A Rare Case of Necrotizing Myopathy after Statin Use Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Pages A237–A238, Available from: URL: https://doi.org/10.1210/jendso/bvac150.487
  13. ^ Brigida Colon Barreto, MD, Hooman Oktaei, MD; Adrenal Insufficiency Associated to Immune Checkpoint Inhibitors ; Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Page A106 Available from: URL: https://doi.org/10.1210/jendso/bvac150.216
  14. ^ Nicole Pant, MD, Hooman Oktaei, MD An Unsolved Mystery of Hyperparathyroidism for 12 Years ; Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Pages A157–A158, Available from: URL: https://doi.org/10.1210/jendso/bvac150.322
  15. ^ M Ghawji, S Dagogo-Jack, H Oktaei. Acute destructive hyperparathyroidism presenting with severe hypercalcemia: a novel association of COVID-19 infection. The American Journal of the Medical Sciences. Volume 365, Supplement 1, February 2023, Page S67 Available from: URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9883777/
  16. ^ Brigida Colon-Barreto, MD ∙ Hooman Oktaei, MD. Dilemma Identifying Pseudohypercalcemia. Endocrine Practice. Volume 29, Issue 5, Supplement S129 May 2023. Available from: URL: https://www.endocrinepractice.org/article/S1530-891X(23)00494-9/fulltext
  17. ^ Zhao Liu MD, Brigida Colon MD, Dilasha Katwal MD, Kanchan Karki MD, Hooman Oktaei MD, Helmut Steinberg MD. Graves' Disease Presenting as Thymic Hyperplasia. Endocrine Practice Volume 29, Issue 5, Supplement, May 2023, Page S106 Available from: URL: https://www.sciencedirect.com/science/article/abs/pii/S1530891X23002987
  18. ^ Brigida Colon Barreto; Stephanie Patrick; Hooman Oktaei; Helmut O Steinberg. Acth Dependent Cushing Syndrome Identification And Management Challenges Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023 Available from: URL: https://doi.org/10.1210/jendso/bvad114.1721
  19. ^ HA Yasin, M. Ghawji, H. Oktaei, S. Dagogo-Jack. Successful treatment with plasmapheresis for a patient with thyroid storm resistant to conventional antithyroid therapies. The American Journal of the Medical SciencesVol. 367SupplementS404Published in issue: February, 2024. Available from: URL: https://www.amjmedsci.org/article/S0002-9629(24)00711-0/pdf
  20. ^ Victoria Beard , Maher Ghawji , Fariha Salman, Hooman Oktaei . Pheochromocytoma Diagnosed During First Trimester of Pregnancy . JCEM Case Reports, Volume 2, Issue 3, March 2024 Available from: URL: https://doi.org/10.1210/jcemcr/luae027
  21. ^ M Ghawji, H Oktaei, A Kellis. A case of dual secreting adrenal neoplasm consistent with pheochromocytoma and cushing syndrome. The American Journal of the Medical Sciences Volume 367, Supplement 1, February 2024, Pages S110-S111 Available from: URL: https://www.sciencedirect.com/science/article/pii/S0002962924002441?via%3Dihub
  22. ^ A Kellis ∙ CS Hastings ∙ H Oktaei. Excess endogenous thyroid hormone years after total thyroidectomy in a patient with metastatic follicular thyroid cancer. The American Journal of Medical Sciences. Volume 369, Supplement 1S559February 2025. Available from: URL: https://www.amjmedsci.com/article/S0002-9629(25)00835-3/fulltext
  23. ^ HA Yasin, CS Hastings, H Oktaei. A rare case of MELAS syndrome presenting in adulthood with prominent gastrointestinal symptoms and lactic acidosis. American Journal of the Medical Sciences 369:p S558-S559, February 2025. DOI: 10.1016/S0002-9629(25)00834-1 Available from: URL: https://www.sciencedirect.com/science/article/pii/S0002962925008341
  24. ^ Camden S. Hastings, Lekshmi R. Nair and Hooman Oktaei. T3 HASHITOXICOSIS IN A PREGNANT PATIENT. The American Journal of the Medical Sciences. Volume 369, Supplement 1, February 2025, Page S118 Available from: URL: https://www.sciencedirect.com/science/article/pii/S0002962925001909?via%3Dihub
  25. ^ Hesham Yasin, Helmut Steinberg, Hooman Oktaei , A rare case of metastatic adrenal cortical carcinoma in a patient who missed follow up for adrenal nodule. The American Journal of Medical Sciences. Volume 369, Supplement 1S560-S561February 2025 Available from: URL: https://www.amjmedsci.com/article/S0002-9629(25)00838-9/fulltext
  26. ^ Amitha Domalpally 1, Samuel A Whittier 1, Qing Pan 2, Dana M Dabelea 3, Christine H Darwin 4, William C Knowler 5, Christine G Lee 6, Jose A Luchsinger 7, Neil H White 8, Emily Y Chew 9; Diabetes Prevention Program Research (DPPOS) Group including Hooman Oktaei, MD, Association of Metformin With the Development of Age-Related Macular Degeneration. JAMA Ophthalmol . 2023 Feb 1;141(2):140-147. doi: 10.1001/jamaophthalmol.2022.5567.PMID: 36547967 PMCID: PMC9936345 DOI: 10.1001/jamaophthalmol.2022.5567
  27. ^ Christine G Lee 1, Adam Ciarleglio 2, Sharon L Edelstein 2, Jill P Crandall 3, Dana Dabelea 4, Ronald B Goldberg 5, Steven E Kahn 6, William C Knowler 2, Maxwell T Ma 6, Neil H White 7, William H Herman 8; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure. Diabetes Care . 2024 May 1;47(5):810-817.PMID: 38502874 PMCID: PMC11043227 DOI: 10.2337/dc23-2009
  28. ^ William C Knowler 1, Lindsay Doherty 2, Sharon L Edelstein 2, Peter H Bennett 3, Dana Dabelea 4, Mary Hoskin 3, Steven E Kahn 5, Rita R Kalyani 6, Catherine Kim 7, F Xavier Pi-Sunyer 8, Sridharan Raghavan 9, Vallabh O Shah 10, Marinella Temprosa 11, Elizabeth M Venditti 12, David M Nathan 13; DPP/DPPOS Research Group including Hooman Oktaei, MD. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes Endocrinol . 2025 Apr 28:S2213-8587(25)00022-1. doi: 10.1016/S2213-8587(25)00022-1. PMID: 40311647 DOI: 10.1016/S2213-8587(25)00022-1
  29. ^ Neil H White 1, Qing Pan 2, William C Knowler 3, Emily B Schroeder 4, Dana Dabelea 5, Emily Y Chew 6, Barbara Blodi 7, Ronald B Goldberg 8, Xavier Pi-Sunyer 9, Christine Darwin 10, Mathias Schlögl 11, David M Nathan 12; Diabetes Prevention Program Outcome Study (DPPOS) Research Group including Hooman Oktaei, MD. Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience. Diabetes Care . 2022 Nov 1;45(11):2653-2661. doi: 10.2337/dc22-0860.PMID: 36098658 PMCID: PMC9679265 DOI: 10.2337/dc22-0860
  30. ^ Josephine H Li 1 2 3 4, James A Perry 5, Kathleen A Jablonski 6, Shylaja Srinivasan 7, Ling Chen 1 3, Jennifer N Todd 1 3 8, Maegan Harden 3, Josep M Mercader 1 2 3 4, Qing Pan 6, Adem Y Dawed 9, Sook Wah Yee 10, Ewan R Pearson 9, Kathleen M Giacomini 10, Ayush Giri 11, Adriana M Hung 12, Shujie Xiao 13, L Keoki Williams 13, Paul W Franks 14, Robert L Hanson 15, Steven E Kahn 16, William C Knowler 15, Toni I Pollin 5, Jose C Florez 1 2 3 4; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP). Diabetes . 2023 Aug 1;72(8):1161-1172. doi: 10.2337/db22-0702. PMID: 36525397 PMCID: PMC10382652 DOI: 10.2337/db22-0702
  31. ^ Neil H White 1, Qing Pan 2, William C Knowler 3, Emily B Schroeder 4, Dana Dabelea 5, Emily Y Chew 6, Barbara Blodi 7, Ronald B Goldberg 8, Xavier Pi-Sunyer 9, Christine Darwin 10, Mathias Schlögl 11, David M Nathan 12; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience. Diabetes Care . 2022 Jul;45(7):1640-1646. doi: 10.2337/dc21-2417. Epub 2022 May 25.PMID: 40315174 PMCID: PMC9375445 DOI: 10.2337/dc21-2417
  32. ^ D Dabelea 1, Y Ma, W C Knowler, S Marcovina, C D Saudek, R Arakaki, N H White, S E Kahn, T J Orchard, R Goldberg, J Palmer, R F Hamman; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabet Med . 2014 Sep;31(9):1064-8. doi: 10.1111/dme.12437. PMID: 24646311 PMCID: PMC4138247 DOI: 10.1111/dme.12437
  33. ^ Marissa M Shams-White 1 2, Ashley H Tjaden 3, Sharon L Edelstein 3, Sarah Bassiouni 4, Lisa L Kahle 5, Catherine Kim 6, Xavier Pi-Sunyer 7, Karla A Temple 8, Elizabeth M Venditti 9, Jill Reedy # 10, Brandy M Heckman-Stoddard # 10; DPP Research Group including Hooman Oktaei, MD. The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS). BMC Nutr . 2022 Sep 21;8(1):105. doi: 10.1186/s40795-022-00596-7.PMID: 36131333 PMCID: PMC9494851 DOI: 10.1186/s40795-022-00596-7
  34. ^ Christine G Lee 1, Brandy Heckman-Stoddard 2, Dana Dabelea 3, Kishore M Gadde 4, David Ehrmann 5, Leslie Ford 2, Philip Prorok 2, Edward J Boyko 6, Xavier Pi-Sunyer 7, Amisha Wallia 8, William C Knowler 9, Jill P Crandall 10, Marinella Temprosa; Diabetes Prevention Program Research Group; Diabetes Prevention Program Research Group including Hooman Oktaei, MD: Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes StudyDiabetes Care . 2021 Dec;44(12):2775-2782.PMID: 34697033 PMCID: PMC8669534 DOI: 10.2337/dc21-1046
  35. ^ Andrea M Kriska 1, Bonny Rockette-Wagner 1, Sharon L Edelstein 2, George A Bray 3, Linda M Delahanty 4, Mary A Hoskin 5, Edward S Horton 6, Elizabeth M Venditti 1, William C Knowler 5; DPP Research Group Collaborators, Affiliations Expand including Hooman Oktaei, MD. The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures. Diabetes Care . 2021 Jan;44(1):43-49. doi: 10.2337/dc20-1129.PMID: 33444158 PMCID: PMC7783946 DOI: 10.2337/dc20-1129
  36. ^ Catherine Kim 1, Sharon L Edelstein, Jill P Crandall, Dana Dabelea, Abbas E Kitabchi, Richard F Hamman, Maria G Montez, Leigh Perreault, Mary A Foulkes, Elizabeth Barrett-Connor; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause . 2011 Aug;18(8):857-68.PMID: 21709591 PMCID: PMC3500880 DOI: 10.1097/gme.0b013e31820f62d0
  37. ^ Jeanne M McCaffery 1, Kathleen A Jablonski, Paul W Franks, Sam Dagogo-Jack, Rena R Wing, William C Knowler, Linda Delahanty, Dana Dabelea, Richard Hamman, Alan R Shuldiner, Jose C Florez; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. PLoS One . 2011;6(7):e21518. doi: 10.1371/journal.pone.0021518. Epub 2011 Jul 26. PMID: 21814547 PMCID: PMC3144193 DOI: 10.1371/journal.pone.0021518
  38. ^ Toni I Pollin 1, Tamara Isakova, Kathleen A Jablonski, Paul I W de Bakker, Andrew Taylor, Jarred McAteer, Qing Pan, Edward S Horton, Linda M Delahanty, David Altshuler, Alan R Shuldiner, Ronald B Goldberg, Jose C Florez, Paul W Franks; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention ProgramPLoS Genet . 2012;8(8):e1002895. doi: 10.1371/journal.pgen.1002895. Epub 2012 Aug 30. PMID: 22951888 PMCID: PMC3431328 DOI: 10.1371/journal.pgen.1002895
  39. ^ Geoffrey A Walford 1, Yong Ma, Costas A Christophi, Ronald B Goldberg, Petr Jarolim, Edward Horton, Kieren J Mather, Elizabeth Barrett-Connor, Jaclyn Davis, Jose C Florez, Thomas J Wang; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program. Diabetologia . 2014 May;57(5):935-9.PMID: 24554005 PMCID: PMC4158711 DOI: 10.1007/s00125-014-3183-2
  40. ^ Allan F Moore 1, Kathleen A Jablonski, Jarred B McAteer, Richa Saxena, Toni I Pollin, Paul W Franks, Robert L Hanson, Alan R Shuldiner, William C Knowler, David Altshuler, Jose C Florez; Diabetes Prevention Program Research Group Collaborators, Affiliations Expand including Hooman Oktaei, MD. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programDiabetes . 2008 Sep;57(9):2503-10. doi: 10.2337/db08-0284. Epub 2008 Jun 10.PMID: 18544707 PMCID: PMC2518503 DOI: 10.2337/db08-0284
  41. ^ E M Venditti 1, G A Bray, M L Carrion-Petersen, L M Delahanty, S L Edelstein, R F Hamman, M A Hoskin, W C Knowler, Y Ma; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes (Lond) . 2008 Oct;32(10):1537-44. PMID: 18711387 PMCID: PMC2574826 DOI: 10.1038/ijo.2008.134
  42. ^ Jose C Florez 1, Kathleen A Jablonski, Jarred B McAteer, Paul W Franks, Clinton C Mason, Kieren Mather, Edward Horton, Ronald Goldberg, Dana Dabelea, Steven E Kahn, Richard F Arakaki, Alan R Shuldiner, William C Knowler; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention ProgramPLoS One . 2012;7(9):e44424. doi: 10.1371/journal.pone.0044424.PMID: 22984506 PMCID: PMC3439414 DOI: 10.1371/journal.pone.0044424
  43. ^ Vanita R Aroda 1 2, Costas A Christophi 3, Sharon L Edelstein 3, Leigh Perreault 4, Catherine Kim 5, Sherita H Golden 6, Edward Horton 7, Kieren J Mather 8; DPP Research Group including Hooman Oktaei, MD. Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program. BMJ Open Diabetes Res Care . 2020 Dec;8(2):e001841. PMID: 33328161 PMCID: PMC7745696 DOI: 10.1136/bmjdrc-2020-001841
  44. ^ Linda M Delahanty 1, Qing Pan, Kathleen A Jablonski, Karol E Watson, Jeanne M McCaffery, Alan Shuldiner, Steven E Kahn, William C Knowler, Jose C Florez, Paul W Franks; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program Diabetes Care . 2012 Feb;35(2):363-6. doi: 10.2337/dc11-1328.PMID: 22179955 PMCID: PMC3263869 DOI: 10.2337/dc11-1328
  45. ^ Elizabeth M Venditti 1, Judith Wylie-Rosett, Linda M Delahanty, Lisa Mele, Mary A Hoskin, Sharon L Edelstein; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence. Int J Behav Nutr Phys Act . 2014 Feb 12:11:16. PMID: 24521153 PMCID: PMC4015875 DOI: 10.1186/1479-5868-11-16
  46. ^ Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program including Hooman Oktaei, MD Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program . Diabetologia . 2014 Mar;57(3):485-90. PMID: 24317794 PMCID: PMC4154629 DOI: 10.1007/s00125-013-3133-4
  47. ^ C A Christophi 1, H E Resnick, R E Ratner, M Temprosa, S Fowler, W C Knowler, H Shamoon, E Barrett-Connor, S E Kahn; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults. J Diabetes Complications . 2013 Mar-Apr;27(2):150-7. PMID: 23140912 PMCID: PMC3594066 DOI: 10.1016/j.jdiacomp.2012.09.012
  48. ^ Jill P Crandall 1, Dana Dabelea 2, William C Knowler 3, David M Nathan 4, Marinella Temprosa 5; DPP Research Group including Hooman Oktaei, MD. The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact. Diabetes Care . 2025 Apr 24:dc250014. doi: 10.2337/dc25-0014. Online ahead of print.PMID: 40272279 DOI: 10.2337/dc25-0014
  49. ^ Jose C Florez 1, Kathleen A Jablonski, Andrew Taylor, Kieren Mather, Edward Horton, Neil H White, Elizabeth Barrett-Connor, William C Knowler, Alan R Shuldiner, Toni I Pollin; Diabetes Prevention Program Research Group including Hooman Oktaei, MD. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program. Diabetes Care . 2012 Sep;35(9):1864-7. doi: 10.2337/dc11-2301. Epub 2012 Jun 29. PMID: 22751958 PMCID: PMC3425006 DOI: 10.2337/dc11-2301
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Hooman_Oktaei&oldid=1291308724"